Cancer Clinical Trials in Austin, Texas

5 studies are recruiting for cancer in Austin, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

    The goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated with standard therapies. The main goals of the study are to understand how safe SYS6043 is, what side effects it may caus…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NEXT Oncology Austin, Austin, Texas
    Locations
    5 in total
    Run by
    Conjupro Biotherapeutics, Inc.

    See if you can join NCT07424547 on ClinicalTrials.gov

  2. Prospective Study to Assess a Diagnostic Aid for Cancer

    The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.

    Stage
    Not phased
    Ages
    45 and older
    Site
    Premier Family Physicians, Austin, Texas
    Locations
    39 in total
    Run by
    Harbinger Health

    See if you can join NCT07046260 on ClinicalTrials.gov

  3. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

    This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NEXT Oncology, Austin, Texas
    Locations
    17 in total
    Run by
    MBrace Therapeutics

    See if you can join NCT06014658 on ClinicalTrials.gov

  4. A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

    This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of OR502 administered as a monotherapy and in combination with cemiplimab in subje…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NEXT Austin, Austin, Texas
    Locations
    4 in total
    Run by
    OncoResponse, Inc.

    See if you can join NCT06090266 on ClinicalTrials.gov

  5. A Study in Patients With Advanced Cancers

    A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NEXT Oncology Austin, Austin, Texas
    Locations
    3 in total
    Run by
    BiOneCure Therapeutics Inc.

    See if you can join NCT05320588 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.